We’ve been eager to let you know about the rollout of a $20 million G-Rex Grant Program which goes live today and is accessible to every cell and gene therapy entity that is moving toward, or already conducting, clinical manufacturing. The program goal is to ensure that every recipient is able to establish the most cost effective manufacture of clinical products in the shortest amount of time. To meet that goal, the G-Rex Grant Program includes a wide range of essential products, services, and expertise that will all be made available to recipients. We hope that academic entities and private companies will take advantage of this program. It’s open to all, designed to be very easy to use, and we’re confident that every participant will find it highly beneficial. This program is possible thanks to the participation of forward-thinking collaborators who are dedicated to making a meaningful impact in the field of cell and gene therapy, including Wilson Wolf Manufacturing, LLC, Bio-Techne, CellReady™, Akadeum Life Sciences, Inc., MaxCyte, Inc., and Vector BioMed, Inc. If there are other like-minded entities that have the ability to help propel our goal, please don’t hesitate to reach out to us. We’d also kindly request that people seeing this message repost it so that it reaches the broadest audience possible. You can learn more about how easy it is to become a recipient of a G-Rex Grant here: https://lnkd.in/eWesmsWJ #cellandgenetherapy #GRex #innovation #collaboration
ScaleReady
Biotechnology Research
St. Paul, Minnesota 4,907 followers
Revolutionizing T-Cell Manufacturing
About us
ScaleReady is a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf. Bringing together proven tools and technologies for cell culture, cell activation, gene editing, and cell processing, ScaleReady provides leading therapeutic developers with the most simple, scalable, and versatile manufacturing platform in the industry.
- Website
-
http://www.scaleready.com
External link for ScaleReady
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- St. Paul, Minnesota
- Type
- Partnership
- Founded
- 2020
Locations
-
Primary
St. Paul, Minnesota, US
Employees at ScaleReady
-
John Wilson
Wilson Wolf CEO focused on solving cell and gene therapy manufacturing challenges
-
Jenny Stjernberg
Building Empowered Teams | Cell Therapy Expert | An injection of positive energy |
-
Tanima A.
Senior Field Application Specialist at ScaleReady
-
Alaina Schlinker
Sr. Manager, Field Application Support at ScaleReady
Updates
-
The Fresenius Kabi Cue® automates labor-intensive and highly variable tasks in the manufacturing workflow. This automated and functionally closed system will provide cell and gene therapy developers a much-needed solution for their commercial-scale cGMP final fill and finish step. Talk to an expert today: https://lnkd.in/eqWgXxxa #cue #cellprocessing #cellandgenetherapy The Cue Cell Processing System is for laboratory use only and may not be used for direct transfusion. Appropriate regulatory clearance is required by the user for clinical use. Refer to the Cue Cell Processing System User's Guide for a complete list of warnings and precautions associated with the use of this device. For additional information, please visit www.scaleready.com/cue
Cue. Your solution to closed-system fill and finish.
https://www.scaleready.com
-
Can you achieve robust T cell expansion without cytokine spiking? The answer is yes! See how the Wilson Wolf Manufacturing, LLC G-Rex and Bio-Techne fill-and-forget method works. https://lnkd.in/exFbaJMQ #celltherapy
G-Rex® Fill-and-Forget Workflow Application Note
https://www.scaleready.com
-
Cell and gene therapies hold immense promise, but ensuring their safety and efficacy requires a robust contamination control strategy (CCS). Our poster explores how G-Rex Bioreactors and Heracell Vios Incubators can simplify parallel processing and significantly reduce contamination risks in CGT manufacturing. Download it now and learn how to achieve highly efficient, cGMP-compliant production: https://lnkd.in/eNhqhjix #celltherapy #genetherapy #CGT
G-Rex Bioreactors and Heracell Vios Incubators and Cross Contamination Prevention
https://www.scaleready.com
-
Flasks and bags just don't cut it anymore for cell therapy production. G-Rex, Wilson Wolf Manufacturing, LLC's innovative bioreactor, offers a unique solution with Gas Permeable Rapid Cell Expansion. In this video, we explore: - The flaws of historical cell culture methods - The science behind G-Rex technology - How G-Rex can improve your cell therapy manufacturing process Watch the full video to unlock the potential of G-Rex: https://lnkd.in/evXtKYFF #celltherapy #manufacturing #G-Rex #ScaleReady
G-Rex - Revolutionizing Cell Therapy Manufacturing
https://www.youtube.com/
-
Level up your cell and gene therapy manufacturing! Download our FREE poster on automated fill and finish solutions: https://lnkd.in/eRi747qB #celltherapy #genetherapy #biotech
Fully Automated and Closed Cell Processing System for Large Scale Final Formulation, Fill and Finish of Engineered T-Cells
https://www.scaleready.com
-
Traditional T cell media often rely on animal components, introducing unnecessary variability and regulatory hurdles. ExCellerate by ScaleReady is the game-changer you've been waiting for! This animal component-free media delivers: • Consistent, reliable results • Simplified regulatory processes • Reduced risk of contamination ️ Download the flyer on our website to see how ExCellerate can streamline your T cell manufacturing workflow! https://lnkd.in/gjmZpxuR #TCellManufacturing #AnimalFree #CellTherapy #Consistency #Reliability #ExCellerate
ExCellerateTM T Cell Media Animal Component-Free Flyer
https://www.scaleready.com
-
"How can we streamline CAR-T cell therapy manufacturing AND cut costs?" One innovative team found the answer. Their switch to G-Rex bioreactors slashed raw material needs and boosted efficiency. Learn their strategy! https://lnkd.in/efQDr2Eb #celltherapy #processoptimization
G-Rex: Expanding the Capabilities of Scalability
https://www.scaleready.com
-
CAR-T cell therapy holds immense promise, but traditional transfection methods can compromise cell health. In this application with Avectas , the health of Triple Knock-Out (KO) transfected T-cells was evaluated by measuring cell expansion and viability in a Gas Permeable Rapid Expansion G-Rex platform using different cell culture media and cytokine supplement. The app note explores: • Solupore®'s performance with Triple Knock-Out (KO) T cells • Consistent expansion across different culture media • High viability throughout the process Download the app note now to unlock the full potential of CAR-T therapies with G-Rex: https://lnkd.in/eN3-psyp #CARTTherapy #CellManufacturing #Solupore #NonViral #Transfection #Efficiency #Viability
Avectas Solupore® and G-Rex® Platform App Note
https://www.scaleready.com
-
Guess what? Today is Embrace Your Geekness Day, and at ScaleReady, we're proudly geeky about science—especially making cell and gene therapy practical and viable. Share your geekiness in the comments! #STEM #GeekPrideDay